DNA microarray for genotyping multidrug-resistant Pseudomonas aeruginosa clinical isolates

Diagn Microbiol Infect Dis. 2007 Nov;59(3):325-38. doi: 10.1016/j.diagmicrobio.2007.06.005. Epub 2007 Sep 20.

Abstract

The management of infections with multidrug-resistant Pseudomonas aeruginosa needs fast and reliable methods of antibiotic susceptibility testing for a therapy improvement. For this purpose, we developed a DNA microarray for genotyping antibiotic resistance and a few virulence factors. The array covers mutations in the efflux regulators mexR, nfxB, mexT, gyrase gyrA, and parC, as well as plasmid-encoded vim, imp, oxa, aph, aac, and aad genes, and virulence-associated mucA and exoU, exoT, and exoS genes, respectively. The whole procedure can be performed in less than 5 h and consists of DNA isolation, target gene amplification, fluorescence labeling, fragmentation, and array hybridization. Concerning the genotype-phenotype comparison in the test collection, the coverage of relevant resistance determinants for antibiotics used in a calculated therapy of critical ill patients was 87.8%.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cross Infection / classification
  • Cross Infection / drug therapy
  • Cross Infection / genetics
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Genotype
  • Humans
  • Microbial Sensitivity Tests
  • Oligonucleotide Array Sequence Analysis / methods*
  • Phenotype
  • Pseudomonas Infections* / classification
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas Infections* / genetics
  • Pseudomonas aeruginosa* / classification
  • Pseudomonas aeruginosa* / drug effects
  • Pseudomonas aeruginosa* / genetics
  • Virulence / genetics